CMR Surgical appoints Daniel Moore as Non-Executive Chairman
July 15 2024 - 7:00AM
CMR Surgical appoints Daniel
Moore as Non-Executive Chairman
- Medical
technology veteran with over 35 years of senior leadership
experience
Cambridge, UK – 15 July 2024, 07:00
(BST). CMR Surgical (CMR or ‘the Company’), the global
surgical robotics business, today announces the appointment of
Daniel (Dan) Moore as Non-Executive Chairman of the Board of
Directors, effective immediately.
Dan Moore is a seasoned executive with over 35
years of both executive and board leadership experience from
several globally renowned medical technology companies, including
Boston Scientific. Dan was most recently the Chairman of the Board
at LivaNova, a medical devices company developing and marketing
neuromodulation and cardiopulmonary products to help improve
patients’ lives.
Prior to the merger of Sorin and Cyberonics to
form LivaNova, Dan was the President and CEO of Cyberonics for
eight years. He has also been an established Board level executive
in the MedTech industry, and served as Chairman at Brainscope, GI
Dynamics and the Medical Device Manufacturers Association (MDMA),
as well as serving on the Board of the Epilepsy Foundation.
Dan first established his medical devices career
at Boston Scientific where he served for nearly 20 years, having
held several senior executive roles, including President of
Inter-Continental and Distribution Management.
As Chairman, Dan will lead the CMR Surgical
Board and work alongside CMR’s board members and executive
leadership team, as they continue to drive the company’s growth
strategy and bring Versius to more hospitals around the world to
make minimal access surgery available to all patients who need
it.
Supratim Bose, Chief Executive Officer
at CMR Surgical, commented: “Daniel has exceptional
experience leading medical technology organisations, and a passion
for how technology can help transform the lives of patients. His
significant sector experience, combined with his strong executive
and board level leadership, will be invaluable to CMR as we
continue to partner with more hospitals around the world, bringing
the benefits of robotic-assisted surgery to more patients.”
Umur Hursever, Partner at
Lightrock and Interim Chairman
commented: “On behalf of the Board, I am delighted
to welcome Daniel Moore as Chairman of CMR Surgical. CMR has now
established itself in the surgical robotics space and I know with
Daniel’s experience the Company will be in an even stronger place
to capitalise on a fast-growing market and deliver against its
mission.”
John Cassidy, Investment Director,
Softbank Investment Advisers and Interim Vice Chair
commented: “We are pleased to have someone of
Dan’s stature join as Chair of the Board. We have a real
opportunity to increase access to robotic-assisted surgery with
Versius and I believe Dan’s deep MedTech experience will be a
substantial asset in ensuring CMR achieves its mission.”
Dan Moore, Non-Executive Chairman at CMR
Surgical, added: “The surgical robotics sector is one of
the most exciting in the MedTech space and Versius is a truly
differentiated technology with many large untapped markets yet to
be reached, and more patients to be served. I look forward to
working with the Board, Supratim and the leadership team to help
realise the vision of the company and true promise of Versius.”
ENDS
Media Contacts:
If you wish to see more, please contact CMR Surgical at:
Press Office, CMR SurgicalT
+44(0) 1223 755801E
pressoffice@cmrsurgical.com
Notes to editors:
The Versius Surgical Robotic System
Versius resets expectations of robotic surgery.
Versius fits into virtually any operating room set-up and
integrates seamlessly into existing workflows, increasing the
likelihood of robotic minimal access surgery (MAS). The small,
portable and modular design of Versius allows the surgeon to only
use the number of arms needed for a given procedure.
Biomimicking the human arm, Versius gives
surgeons the choice of optimised port placement alongside the
dexterity and accuracy of small fully-wristed instruments. With 3D
HD vision, easy-to adopt instrument control and a choice of
ergonomic working positions, the open surgeon console has the
potential to reduce stress and fatigue and allows for clear
communication with the surgical team. By thinking laparoscopically
and operating robotically with Versius, patients, surgeons and
healthcare professionals can all benefit from the value that
robotic MAS brings.
But it’s more than just a robot. Versius
captures meaningful data with its wider digital ecosystem to
support a surgeon’s continuous learning. Through the Versius
Connect app, Versius Trainer and CMR clinical registry, Versius
unleashes a wealth of insights to ultimately improve surgical
care.
About CMR Surgical Limited
CMR Surgical (CMR) is a global medical devices
company dedicated to transforming surgery with Versius, a
next-generation surgical robot.
Headquartered in Cambridge, United Kingdom, CMR is committed to
working with surgeons, surgical teams and hospital partners, to
provide an optimal tool to make robotic minimal access surgery
universally accessible and affordable. With Versius, we are on a
mission to redefine the surgical robotics market with practical,
innovative technology and data that can improve surgical care.
Founded in 2014, CMR Surgical is a private
limited company backed by an international shareholder base.